Melanoma Institute Australia shines at prestigious Cancer Research Awards

Melanoma Institute Australia shines at prestigious Cancer Research Awards

3 November 2018

Leading researchers from Melanoma Institute Australia have taken out the top accolades at the NSW Premier’s Awards for Outstanding Cancer Research.

Professor Georgina Long, Co-Medical Director of Melanoma Institute Australia, has won the top award for Outstanding Cancer Researcher of the Year. One of the world’s pre-eminent melanoma clinicians and researchers, Professor Long has changed the face of melanoma treatment around the world with her ground-breaking clinical trials tripling life expectancy for patients with advanced melanoma and curing a significant subset.

Fellow MIA Co-Medical Director, Professor Richard Scolyer, has been awarded The Professor Rob Sutherland AO Make a Difference Award, which is awarded in recognition of lasting impact and sustained progress to cancer care or research practice. Professor Scolyer is the world’s leading melanoma pathologist, each year receiving more than 2,000 cases for review and opinion from around the world. He recently co-edited the new WHO Classification of Skin Tumours, 4th Edition.

Also awarded were MIA’s Associate Professor Alex Menzies, who won the Outstanding Cancer Research Fellow Award with less than five years post-doctoral experience in research, and Associate Professor Anne Cust, who was awarded Outstanding Cancer Research Fellow with more than five years post-doctoral experience in research.

Associate Professor Menzies is a Medical Oncologist with research interest in clinical trials of new systemic therapies for melanoma, biomarkers of response and resistance to systemic therapy, and immunotherapy-related toxicity. Associate Professor Cust is an epidemiologist whose research focuses on melanoma epidemiology, prevention, early detection and survivorship and has a strong emphasis on translational outcomes.

Melanoma Institute Australia CEO Matthew Browne said it was a proud moment to see Melanoma Institute Australia’s research and clinical team centre stage at the prestigious awards night.

‘This is well deserved recognition for not only these award winners, but also the multi-disciplinary teams across MIA that work tirelessly to develop new treatments to save lives from melanoma,’ Mr Browne said.

‘My particular congratulations go to Professor Long for taking out the prestigious Outstanding Cancer Researcher of the Year Award. This is testament to her research and global thought leadership which has set the world on the path towards advanced melanoma becoming a chronic disease rather than a terminal one.

‘She was gracious in acknowledging the award was recognition of the whole team’s efforts at MIA, and particularly her long research partnership with Professor Richard Scolyer.

‘With the breakthroughs in melanoma treatment also set to revolutionise treatments for other cancers, Professor Long’s legacy will potentially impact millions across the globe.’

Melanoma March Bibs
19 Mar 2015

Melanoma March Bibs

If you would like to download a bib for your Melanoma March, we have a selection for you to choose from, print and bring along with you on the day. 

Manly Melanoma March
17 Mar 2015

Manly Melanoma March

Manly Melanoma March has changed to a new location. 

Q&A with Melanoma March Fundraisers
10 Mar 2015

Q&A with Melanoma March Fundraisers

We did a short Q&A with two sisters who are raising funds for Melanoma March after sadly losing their mother in 2009. This is their second march and they have shared with us their fundraising tips. 

Research Director Graham Mann explains where Melanoma March funds are going
10 Mar 2015

Research Director Graham Mann explains where Melanoma March funds are going

We want to share with you what your valuable Melanoma March donation and fundraising goes towards and our Research Director, Graham Mann explains the national research project the funds will be going towards.

First patient recruited to the EAGLE FM Trial
09 Mar 2015

First patient recruited to the EAGLE FM Trial

Evaluation of Groin Lymphadenectomy Extent for Metastatic Melanoma (EAGLE FM) clinical trial has recruited its first patient.  

Online Comments to the Pharmaceutical Benefits Advisory Committee
09 Feb 2015

Online Comments to the Pharmaceutical Benefits Advisory Committee

You are invited to provide comments for consideration by the Pharmaceutical Benefits Advisory Committee (PBAC). The PBAC will consider the registration of the anti-PD1 drug, Keytruda (pembrolizumab) at the next meeting in March.

A man of commitment
06 Feb 2015

A man of commitment

Melanoma patient Joel Allsop was congratulated today on completing his participation in the international surgical clinical trial, known as MSLT-II. He was the first person in the world to complete the 10 years of follow-up for this trial. 

Melanoma March has officially launched
05 Feb 2015

Melanoma March has officially launched

Melanoma Institute Australia (MIA) has officially launched the 2015 ‘Melanoma March’ initiative in Melbourne. 

Melanoma March is around the corner
02 Feb 2015

Melanoma March is around the corner

Help us march towards a cure for melanoma research. See where your local march is and how you can get involved.

Q&A with a PhD student
28 Jan 2015

Q&A with a PhD student

Under the leadership of world-leading melanoma pathologist Prof Richard Scolyer and medical oncologist A/Prof Georgina Long, third year PhD student, Hojabr Kakavand, is at the forefront of melanoma research. 

ClinTrial Refer Melanoma App
22 Jan 2015

ClinTrial Refer Melanoma App

Melanoma Institute Australia has launched a new smartphone app called ClinTrial Refer Melanoma to help busy clinicians find clinical trials for their melanoma patients.

Interview on the latest melanoma treatments
08 Jan 2015

Interview on the latest melanoma treatments

MIA's Associate Professor Georgina Long and stage 4 melanoma patient, Maria, were recently interviewed by ABC Weekend Breakfast about the latest in clincial trials and melanoma treatments.

Sunbed campaigner acknowledged as one of most influential Australians
17 Dec 2014

Sunbed campaigner acknowledged as one of most influential Australians

Sunbed campaigner, Jay Allen, has been acknowledged on the honour roll of Australia’s most influential people in the non-profit sector.

A world-class organisation needs a world-class website
03 Dec 2014

A world-class organisation needs a world-class website

Today we launch the website we’ve dreamed about!

Watch Your Mate's Back kicks off
01 Dec 2014

Watch Your Mate's Back kicks off soon

Our new summer campaign has you and your mates' backs covered!

Saving our next generation
18 Nov 2014

Saving our next generation

Researcher James Wilmott is working to fill a gap in research for young patients.

It's time to march for a cure!
17 Nov 2014

It's time to march for a cure!

Join us for our fourth annual Melanoma March and help us raise over $1 million for melanoma research as we march for a cure! 

Making a difference
17 Nov 2014

Making a difference

When Melanoma Institute Australia (MIA) patients at the Poche Centre are first diagnosed with advanced melanoma Anna Hoadley is there.

New trial offers hope to Stage IV patients
17 Nov 2014

New trial offers hope to Stage IV patients

Shining new hope for patients with advanced stage melanoma.

Combination drug therapy halts disease in advanced melanoma
29 Sep 2014

Combination drug therapy halts disease in advanced melanoma

A world-first study in the New England Journal of Medicine heralds the effectiveness of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.